Oventus Medical (OVN) Short Interest

Oventus Medical (ASX:OVN) had 0.00% of shares reported as short positions as of 31 Aug 2020, representing 351 shares. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Oventus Medical logo
OVN

Oventus Medical

Oventus Medical specializes in developing innovative medical devices for the treatment of sleep apnea and other breathing-related conditions. The company leverages its proprietary airway technology to offer unique solutions that improve patient comfort and compliance. Positioned in the healthcare sector, Oventus aims to transform the management of sleep disorders with its cutting-edge products.

Short position

short percentage0.00%
reported shorts351
shares on issue158.262M

Oventus Medical (ASX:OVN) has 0.00% of its shares on issue reported as short positions as of 31 Aug 2020, or about 351 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

OVN intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required
Short interest history & FAQ

Company

AI-generated research profile of Oventus Medical

medical devices
healthcare
innovation
dental
sleep apnea

About

Connect

Be the first to discuss OVN

Start a research thread or post the first pulse update